Kai Juhani Kauppinen

Research activity per year

Filter

2022

Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain
Kauppinen, K. J., Aho, I. & Sutinen, J., 1 Aug 2022, In: AIDS. 36, 10, p. 1337-1344 8 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
2021

Prevalence of obesity and disturbances in glucose homeostasis in HIV-infected subjects and general population - missed diagnoses of diabetes?
Hanttu, A., Kauppinen, K. J., Kivelä, P., Ollgren, J., Jousilahti, P., Liitsola, K., Koponen, P. & Sutinen, J., 2021, In: HIV Medicine. 22, 4, p. 244-253 10 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Open Access
File
2019

Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting
Kauppinen, K. J., Kivelä, P. & Sutinen, J., Dec 2019, In: AIDS Patient Care and STDs. 33, 12, p. 500-506 7 p.
Research output: Contribution to journal › Article › Scientific › peer-review

Publications